Search Results
Feb 26, 2026, 22:41 ET Changingtek Robotics lance la première main adaptative « X2 » gauche-droite au monde
https://youtu.be/Ay3KCk7ZuWEContact :Changingtek Robotics Technology (Suzhou) Co., Ltd.Tél : +86 512 5323 3370 / +86 158 7124 2390WhatsApp : +86 158 7124 2390E-mail : [email protected]
More news about: Changingtek Robotics Technology (suzhou) Co., Ltd.
Feb 26, 2026, 22:06 ET RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 20:58 ET INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
Information:Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 20:32 ET FBRT Investors Have Opportunity to Lead Franklin BSP Realty Trust, Inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm
Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 20:13 ET CRWV Deadline: CRWV Investors Have Opportunity to Lead CoreWeave, Inc. Securities Fraud Lawsuit
Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 18:41 ET Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 18:26 ET RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) [email protected]
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 15:50 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTGN
or 80.25%, to close at $0.861 per share on December 17, 2025.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:50 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Sale of Endeavor Group Holdings, Inc. Class A Common Stock of Class Action Lawsuit and Upcoming Deadlines - EDR
information needed to render those assertions not misleading.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:20 ET PRIVACY ALERT: CatalystRCM Under Investigation for Data Breach of More Than 139,000 Records
DixitSchubert Jonckheer & Kolbe [email protected] Tel: 415-299-8207
More news about: Schubert Jonckheer & Kolbe LLP
Feb 26, 2026, 15:20 ET Santander anuncia novo campus corporativo em São Paulo a ser desenvolvido pela GTIS Partners com inauguração prevista para o segundo semestre de 2028
Beatriz Imenes, Eduarda Lopes e equipe – www.planin.com Tel.: (11) 2138-8940 - Cel.: (11) 98758-6504 - [email protected] -
More news about: GTIS
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
or 80.14%, to close at $0.423 per share on February 23, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Marriott Vacations Worldwide Corporation - VAC
Marriott Vacations' stock price fell sharply, damaging investors.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Planet Fitness, Inc. - PLNT
or 8.97%, to close at $82.61 per share on February 24, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alight, Inc. - ALIT
or 38.17%, to close at $0.81 per share on February 19, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
or 16.51%, to close at $17.04 per share on February 20, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EPAM Systems, Inc. - EPAM
sessions, to close at $129.96 per share on February 23, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tennant Company - TNC
or 23.43%, to close at $63.02 per share on February 24, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Solar, Inc. - FSLR
13.61%, to close at $210.12 per share on February 25, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stellantis N.V. - STLA
or 23.69%, to close at $7.28 per share on February 6, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DNOW Inc. - DNOW
or 19.13%, to close at $13.23 per share on February 20, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oddity Tech Ltd. - ODD
or 49.21%, to close at $14.74 per share on February 25, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
or 16.43%, to close at $39.63 per ADR on February 23, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMC
or 19.54%, to close at $13.67 per share on February 5, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Driven Brands Holdings Inc. - DRVN
or 30.16%, to close at $11.60 per share on February 25, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham
More news about: Pomerantz LLP